Here are four highlights:
1. When PrEP is taken as a daily pill, it reduces the risk of HIV infection by more than 90 percent in sexually active patients.
2. The FDA approved the drug in 2012.
3. It minimizes intravenous drug users’ risk of infection by 70 percent.
4. Each year, nearly 40,000 people are diagnosed with HIV infections.
More articles on quality & infection control:
Hand hygiene startup Sterilogy receives $25k award
CMS seeking comments for new patient survey: 5 things to know
Outpatient ASC quality data reporting: CMS gives Press Ganey thumbs-up for 2016 — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
